Our data suggest that PP6 deficiency or phosphatase inactivation may confer a survival advantage to tumor cells in response to TNFα-mediated killing in tumor microenvironment and thereby may allow immune evasion to promote tumorigenesis. This evidence concerns the gene PPP6C and neoplasm.